✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals

Mahamaya Lifesciences Ltd.

MAHALIFE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹321 Cr.
P/E
24.81

Mahamaya Lifesciences Ltd.

  • Mahamaya Lifescience
  • Nova Agritech
  • Bhagiradha Chem

FAQs on Mahamaya Lifesciences Ltd. Shareprice

There is not enough historical data for the companies share price.

Yes, Mahamaya Lifescience is expensive.
Latest PE of Mahamaya Lifescience is 24.81, while 3 year average PE is 22.47.
Also latest EV/EBITDA of Mahamaya Lifescience is 13.0 while 3yr average is 12.88.

View FAQ's On Business

Growth Table

  • Mahamaya Lifesciences Ltd.
  • Nova Agritech
  • Bhagiradha Chem

Balance Sheet

  • Mahamaya Lifesciences Ltd.
  • Nova Agritech
  • Bhagiradha Chem

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Mahamaya Lifesciences Ltd.
  • Nova Agritech
  • Bhagiradha Chem

Cash Flow

  • Mahamaya Lifesciences Ltd.
  • Nova Agritech
  • Bhagiradha Chem

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Mahamaya Lifesciences Ltd.
  • Nova Agritech
  • Bhagiradha Chem

Quarterly Results

  • Mahamaya Lifesciences Ltd.
  • Nova Agritech
  • Bhagiradha Chem

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Mahamaya Lifesciences Ltd. Financials

Balance sheet of Mahamaya Lifescience is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Mahamaya Lifescience is increasing.
Latest net debt of Mahamaya Lifescience is ₹64.11 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹50.51 Crs.

Yes, profit is increasing.
The profit of Mahamaya Lifescience is ₹15.62 Crs for TTM, ₹12.94 Crs for Mar 2025 and ₹5.22 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Mahamaya Lifescience latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech